HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
There is a growing body of evidence that HER2 status can change during disease recurrence or progression in breast cancer patients. In this context, re-evaluation of HER2 status by assessment of HER2 expression on circulating tumor cells (CTCs) is …
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
01.11.2010
|
| In: |
Breast cancer research and treatment
Year: 2010, Jahrgang: 124, Heft: 2, Pages: 403-412 |
| ISSN: | 1573-7217 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://www.springermedizin.de/her2-status-of-circulating-tumor-cells-in-patients-with-metastat/8842548
|
| Verfasserangaben: | Tanja Fehm, Volkmar Müller, Bahriye Aktas, Wolfgang Janni, Andreas Schneeweiss, Elmar Stickeler, Claus Lattrich, Christian R. Löhberg, Erich Solomayer, Brigitte Rack, Sabine Riethdorf, Christoph Klein, Christian Schindlbeck, Kerstin Brocker, Sabine Kasimir-Bauer, Diethelm Wallwiener, Klaus Pantel |
| Zusammenfassung: | There is a growing body of evidence that HER2 status can change during disease recurrence or progression in breast cancer patients. In this context, re-evaluation of HER2 status by assessment of HER2 expression on circulating tumor cells (CTCs) is … |
|---|---|
| Beschreibung: | Gesehen am 23.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1573-7217 |